Selected research
Industry Research
Ferric Carboxymaltose Injection Industry Research Report 2026
Market perspective
The global Ferric Carboxymaltose Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ferric Carboxymaltose Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ferric Carboxymaltose Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ferric Carboxymaltose Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ferric Carboxymaltose Injection include Hencer Pharma, Daiichi Sankyo, Bosch Pharmaceuticals, Weefsel Pharma, Vifor Pharma, Lupin, Cipla and Apollo Pharmacy, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ferric Carboxymaltose Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ferric Carboxymaltose Injection Market by Company
Hencer Pharma
Daiichi Sankyo
Bosch Pharmaceuticals
Weefsel Pharma
Vifor Pharma
Lupin
Cipla
Apollo Pharmacy
Ferric Carboxymaltose Injection Segment by Type
2 ml
10 ml
20 ml
15 ml
Ferric Carboxymaltose Injection Segment by Application
Hospital
Clinic
Ferric Carboxymaltose Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ferric Carboxymaltose Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ferric Carboxymaltose Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ferric Carboxymaltose Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ferric Carboxymaltose Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ferric Carboxymaltose Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ferric Carboxymaltose Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2 ml
- 10 ml
- 20 ml
- 15 ml
Applications
- Hospital
- Clinic
Companies covered
- Hencer Pharma
- Daiichi Sankyo
- Bosch Pharmaceuticals
- Weefsel Pharma
- Vifor Pharma
- Lupin
- Cipla
- Apollo Pharmacy
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ferric Carboxymaltose Injection Market Size (2021-2032)
- 2.2.2 Global Ferric Carboxymaltose Injection Sales (2021-2032)
- 2.2.3 Global Ferric Carboxymaltose Injection Market Average Price (2021-2032)
- 2.3 Ferric Carboxymaltose Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 2 ml
- 2.3.3 10 ml
- 2.3.4 20 ml
- 2.3.5 15 ml
- 2.4 Ferric Carboxymaltose Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ferric Carboxymaltose Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ferric Carboxymaltose Injection Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Ferric Carboxymaltose Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Ferric Carboxymaltose Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Ferric Carboxymaltose Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ferric Carboxymaltose Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ferric Carboxymaltose Injection, Product Type & Application
- 3.8 Global Manufacturers of Ferric Carboxymaltose Injection, Established Date
- 3.9 Global Ferric Carboxymaltose Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Hencer Pharma
- 4.1.1 Hencer Pharma Company Information
- 4.1.2 Hencer Pharma Business Overview
- 4.1.3 Hencer Pharma Ferric Carboxymaltose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Hencer Pharma Ferric Carboxymaltose Injection Product Portfolio
- 4.1.5 Hencer Pharma Recent Developments
- 4.2 Daiichi Sankyo
- 4.2.1 Daiichi Sankyo Company Information
- 4.2.2 Daiichi Sankyo Business Overview
- 4.2.3 Daiichi Sankyo Ferric Carboxymaltose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Daiichi Sankyo Ferric Carboxymaltose Injection Product Portfolio
- 4.2.5 Daiichi Sankyo Recent Developments
- 4.3 Bosch Pharmaceuticals
- 4.3.1 Bosch Pharmaceuticals Company Information
- 4.3.2 Bosch Pharmaceuticals Business Overview
- 4.3.3 Bosch Pharmaceuticals Ferric Carboxymaltose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bosch Pharmaceuticals Ferric Carboxymaltose Injection Product Portfolio
- 4.3.5 Bosch Pharmaceuticals Recent Developments
- 4.4 Weefsel Pharma
- 4.4.1 Weefsel Pharma Company Information
- 4.4.2 Weefsel Pharma Business Overview
- 4.4.3 Weefsel Pharma Ferric Carboxymaltose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Weefsel Pharma Ferric Carboxymaltose Injection Product Portfolio
- 4.4.5 Weefsel Pharma Recent Developments
- 4.5 Vifor Pharma
- 4.5.1 Vifor Pharma Company Information
- 4.5.2 Vifor Pharma Business Overview
- 4.5.3 Vifor Pharma Ferric Carboxymaltose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Vifor Pharma Ferric Carboxymaltose Injection Product Portfolio
- 4.5.5 Vifor Pharma Recent Developments
- 4.6 Lupin
- 4.6.1 Lupin Company Information
- 4.6.2 Lupin Business Overview
- 4.6.3 Lupin Ferric Carboxymaltose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Lupin Ferric Carboxymaltose Injection Product Portfolio
- 4.6.5 Lupin Recent Developments
- 4.7 Cipla
- 4.7.1 Cipla Company Information
- 4.7.2 Cipla Business Overview
- 4.7.3 Cipla Ferric Carboxymaltose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Cipla Ferric Carboxymaltose Injection Product Portfolio
- 4.7.5 Cipla Recent Developments
- 4.8 Apollo Pharmacy
- 4.8.1 Apollo Pharmacy Company Information
- 4.8.2 Apollo Pharmacy Business Overview
- 4.8.3 Apollo Pharmacy Ferric Carboxymaltose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Apollo Pharmacy Ferric Carboxymaltose Injection Product Portfolio
- 4.8.5 Apollo Pharmacy Recent Developments
5 Global Ferric Carboxymaltose Injection Market Scenario by Region
- 5.1 Global Ferric Carboxymaltose Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ferric Carboxymaltose Injection Sales by Region: 2021-2032
- 5.2.1 Global Ferric Carboxymaltose Injection Sales by Region: 2021-2026
- 5.2.2 Global Ferric Carboxymaltose Injection Sales by Region: 2027-2032
- 5.3 Global Ferric Carboxymaltose Injection Revenue by Region: 2021-2032
- 5.3.1 Global Ferric Carboxymaltose Injection Revenue by Region: 2021-2026
- 5.3.2 Global Ferric Carboxymaltose Injection Revenue by Region: 2027-2032
- 5.4 North America Ferric Carboxymaltose Injection Market Facts & Figures by Country
- 5.4.1 North America Ferric Carboxymaltose Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ferric Carboxymaltose Injection Sales by Country (2021-2032)
- 5.4.3 North America Ferric Carboxymaltose Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Ferric Carboxymaltose Injection Market Facts & Figures by Country
- 5.5.1 Europe Ferric Carboxymaltose Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ferric Carboxymaltose Injection Sales by Country (2021-2032)
- 5.5.3 Europe Ferric Carboxymaltose Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Ferric Carboxymaltose Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ferric Carboxymaltose Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ferric Carboxymaltose Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ferric Carboxymaltose Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ferric Carboxymaltose Injection Market Facts & Figures by Country
- 5.7.1 South America Ferric Carboxymaltose Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ferric Carboxymaltose Injection Sales by Country (2021-2032)
- 5.7.3 South America Ferric Carboxymaltose Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Ferric Carboxymaltose Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ferric Carboxymaltose Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ferric Carboxymaltose Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ferric Carboxymaltose Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Ferric Carboxymaltose Injection Sales by Type (2021-2032)
- 6.1.1 Global Ferric Carboxymaltose Injection Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Ferric Carboxymaltose Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Ferric Carboxymaltose Injection Revenue by Type (2021-2032)
- 6.2.1 Global Ferric Carboxymaltose Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ferric Carboxymaltose Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Ferric Carboxymaltose Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ferric Carboxymaltose Injection Sales by Application (2021-2032)
- 7.1.1 Global Ferric Carboxymaltose Injection Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Ferric Carboxymaltose Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Ferric Carboxymaltose Injection Revenue by Application (2021-2032)
- 7.2.1 Global Ferric Carboxymaltose Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ferric Carboxymaltose Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Ferric Carboxymaltose Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ferric Carboxymaltose Injection Value Chain Analysis
- 8.1.1 Ferric Carboxymaltose Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ferric Carboxymaltose Injection Production Mode & Process
- 8.2 Ferric Carboxymaltose Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ferric Carboxymaltose Injection Distributors
- 8.2.3 Ferric Carboxymaltose Injection Customers
9 Global Ferric Carboxymaltose Injection Analyzing Market Dynamics
- 9.1 Ferric Carboxymaltose Injection Industry Trends
- 9.2 Ferric Carboxymaltose Injection Industry Drivers
- 9.3 Ferric Carboxymaltose Injection Industry Opportunities and Challenges
- 9.4 Ferric Carboxymaltose Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst